# AI QUALITY CHECK RESULTS

**Reviewer:** AI Final-Pass Quality Checker
**Date:** February 24, 2026
**Documents Reviewed:**
1. `01_VV_Technical_Brief.md` (VV Technical Implementation Brief)
2. `02_Implementation_Guide.md` (3C Platform Implementation Guide)

**Classification:** Internal -- Authentic Consortium

---

## SUMMARY

| Category | Critical | Major | Minor | Info |
|---|---|---|---|---|
| Placeholder Detection | 0 | 0 | 0 | 0 |
| Cross-Document Consistency | 0 | 3 | 2 | 0 |
| Accuracy / Contradictions | 0 | 2 | 3 | 0 |
| Grammar & Spelling | 0 | 0 | 4 | 0 |
| Formatting | 0 | 1 | 2 | 0 |
| Tone | 0 | 0 | 0 | 1 |
| Completeness | 0 | 2 | 1 | 0 |
| **TOTAL** | **0** | **8** | **12** | **1** |

---

## 1. PLACEHOLDER DETECTION

No placeholders found. All data fields are populated.

---

## 2. CROSS-DOCUMENT CONSISTENCY

### ISSUE C-1 (MAJOR): CRM Analytics referenced inconsistently between documents
- **File:** `01_VV_Technical_Brief.md`, Lines 94, 132
- **Text (Line 94):** `Salesforce Health Cloud CRM Analytics + VV predictive models`
- **Text (Line 132):** `Salesforce CRM Analytics + VV scoring models`
- **File:** `02_Implementation_Guide.md`, Line 28
- **Text:** `Salesforce Reports & Dashboards (Phase 1); CRM Analytics (Phase 2+)`
- **Issue:** The Technical Brief references "CRM Analytics" as part of the Phase 1 compliance and billing dashboards (lines 94, 132), but the Implementation Guide correctly identifies CRM Analytics as a Phase 2 add-on (not included in Health Cloud Enterprise). The Brief should reference "Salesforce Reports & Dashboards" for Phase 1 capabilities.
- **Fix:** Change Brief Line 94 from `Salesforce Health Cloud CRM Analytics` to `Salesforce Health Cloud Reports & Dashboards (Phase 1; CRM Analytics Phase 2+)`. Change Brief Line 132 similarly.

### ISSUE C-2 (MAJOR): NLP for coding described in Phase 1 MVP diagram
- **File:** `02_Implementation_Guide.md`, Lines 48--50
- **Text:** Phase 1 MVP architecture diagram shows `Basic NLP for coding suggestions (spaCy + MedCAT)` as part of the Phase 1 custom AI microservices
- **File:** `02_Implementation_Guide.md`, Line 182
- **Text:** Coding Optimization is listed as `Phase 2`
- **Issue:** The Phase 1 architecture diagram includes NLP coding suggestions, but the module build specification table places coding optimization in Phase 2. The diagram should be consistent with the build specification.
- **Fix:** Change lines 48--50 in the diagram from `Basic NLP for coding` / `suggestions (spaCy +` / `MedCAT)` to `FHIR data transforms` / `(device -> Observation)` or remove the NLP line and add a Phase 1 capability instead.

### ISSUE C-3 (MAJOR): Phase 2 total cost summary does not reflect updated MuleSoft pricing
- **File:** `02_Implementation_Guide.md`, Line 358
- **Text:** `~$300,000--$400,000`
- **Issue:** The Phase 2 Salesforce subtotal was updated from ~$118,700 to ~$148,700 (MuleSoft increase from $50K to $80K). However, the total cost summary on line 358 still shows `~$300,000--$400,000` for Phase 2. With the $30K increase in Salesforce costs, the lower bound should be closer to ~$330,000.
- **Fix:** Update line 358 Phase 2 cash cost to `~$330,000--$430,000` and total value to `~$480,000--$580,000`.

### ISSUE C-4 (MINOR): "Silverline" referenced as small firm in partner section
- **File:** `02_Implementation_Guide.md`, Line 371
- **Text:** `Small Salesforce Health Cloud partners: Silverline, Penrod, or local Virginia firms`
- **Issue:** Silverline was acquired by NTT Data in 2022 and is no longer a small firm. Penrod is mid-market. Both typically have engagement minimums ($50K--$200K+) exceeding the entire grant budget.
- **Fix:** Change to `Salesforce Health Cloud partners: independent consultants (Upwork/Toptal), Salesforce Trailblazer community referrals, or local Virginia firms`

### ISSUE C-5 (MINOR): Technical Brief line 94 says "CRM Analytics" for CMS Quality Dashboard -- should say Reports & Dashboards for Phase 1
- **File:** `01_VV_Technical_Brief.md`, Line 94
- **Issue:** Duplicate of C-1. CMS Quality Dashboard in Phase 1 should use standard Salesforce Reports & Dashboards, not CRM Analytics.
- **Fix:** See C-1 fix above.

---

## 3. ACCURACY / CONTRADICTIONS

### ISSUE A-1 (MAJOR): MuleSoft cost stated as "$50K/year minimum" in text but $80K in table
- **File:** `02_Implementation_Guide.md`, Line 71
- **Text:** `MuleSoft starts at ~$50K/year minimum`
- **File:** `02_Implementation_Guide.md`, Line 328
- **Text:** `~$80,000 (minimum; negotiate with Salesforce AE)`
- **Issue:** The textual description in Section 2.2 still says $50K/year, but the cost table in Section 6.1 was updated to $80K. These should be consistent.
- **Fix:** Change line 71 from `MuleSoft starts at ~$50K/year minimum` to `MuleSoft starts at ~$80K/year minimum`.

### ISSUE A-2 (MAJOR): Revenue calculation assumes $103.88/month per RPM patient, but new 2026 codes could increase this
- **File:** `02_Implementation_Guide.md`, Lines 208, 194--195
- **Issue:** The revenue table uses $103.88/month (99454 + 99457 only), but the new 2026 codes (99445 for 2--15 day monitoring and 99470 for shorter interactions) expand billing opportunities. With 99445, clinics can bill even when patients don't meet the 16-day threshold. This could increase RPM revenue per patient by 20--30% in practice. The revenue estimate is conservative, which is appropriate, but a footnote about the new codes' impact would strengthen the revenue story.
- **Fix (optional):** Add a note under the revenue table: "Note: New 2026 CPT codes (99445, 99470) enable billing for 2--15 day monitoring periods and shorter clinician interactions, potentially increasing per-patient RPM revenue beyond these conservative estimates."

### ISSUE A-3 (MINOR): "Best in KLAS 2025" claim for athenahealth
- **File:** `02_Implementation_Guide.md`, Line 83
- **Text:** `Best in KLAS 2025 for independent practices`
- **Issue:** KLAS awards vary by category and year. Verify this claim is accurate for the specific 2025 category. athenahealth has consistently performed well in KLAS rankings for small/independent practices, so this is likely correct but should be cited.
- **Fix:** Acceptable as-is for an internal document. For external use, cite the specific KLAS category.

### ISSUE A-4 (MINOR): "850K+ physicians" claim for eClinicalWorks
- **File:** `02_Implementation_Guide.md`, Line 82
- **Text:** `largest cloud ambulatory install base, 850K+ physicians`
- **Issue:** This figure is commonly cited by eCW in their marketing materials but may include all users (physicians, mid-levels, nurses) rather than strictly physicians. The claim is directionally correct but potentially overstated.
- **Fix:** Change to `largest cloud ambulatory install base, 850K+ healthcare professionals` or verify the exact claim from eCW's current marketing.

### ISSUE A-5 (MINOR): RPM device cost for pilot listed as $1,500 for 10--15 units
- **File:** `02_Implementation_Guide.md`, Line 265
- **Text:** `RPM devices for pilot (10--15 units) | $1,500`
- **Issue:** At $80--$150 per blood pressure cuff (line 104), 10--15 units = $800--$2,250. The $1,500 figure is plausible if using a mix of devices and negotiating pilot pricing, but tight at the upper end of the device count. This is acceptable but warrants awareness during budgeting.
- **Fix:** Acceptable as-is. Consider noting this assumes pilot/volume pricing from the device vendor.

---

## 4. GRAMMAR & SPELLING

### ISSUE G-1 (MINOR): "Heath care" typo in partner section
- **File:** `02_Implementation_Guide.md`, Line 380
- **Text:** `Heath care IT law firm (Virginia-based)`
- **Fix:** Change to `Healthcare IT law firm (Virginia-based)`

### ISSUE G-2 (MINOR): Inconsistent capitalization of "Salesforce" product names
- **Files:** Both documents
- **Issue:** "Salesforce Connect" is used correctly, but some references use "Salesforce Health Cloud" and others use "Health Cloud" without the "Salesforce" prefix. This is acceptable but should be consistent at first mention (full name) and subsequent mentions (short name).
- **Fix:** No change required -- current usage is acceptable for internal documents.

### ISSUE G-3 (MINOR): Double-dash (--) used as em-dash throughout
- **Files:** Both documents
- **Issue:** All documents use `--` for em dashes, which is a common Markdown convention. This is internally consistent.
- **Fix:** No change required for Markdown. The PDF conversion script should handle this correctly if it converts `--` to proper em dashes. Verify in PDF output.

### ISSUE G-4 (MINOR): "first-hand" inconsistency with DoD document conventions
- **File:** `01_VV_Technical_Brief.md`
- **Issue:** The word "first-hand" does not appear in the VIPC documents, but if added, it should be hyphenated for consistency with the DIU Proposal documents.
- **Fix:** No change required -- word does not appear in current VIPC documents.

---

## 5. FORMATTING

### ISSUE F-1 (MAJOR): Phase 1 MVP architecture diagram shows NLP that is Phase 2
- **File:** `02_Implementation_Guide.md`, Lines 48--50
- **Issue:** Duplicate of C-2. The ASCII diagram includes NLP for coding suggestions as a Phase 1 component, but the build spec places this in Phase 2.
- **Fix:** See C-2.

### ISSUE F-2 (MINOR): Technical Brief architecture diagram could benefit from Phase markers
- **File:** `01_VV_Technical_Brief.md`, Lines 42--77
- **Issue:** The architecture diagram shows the full vision (all modules) without Phase markers. The Brief correctly marks Phase 2/3 features in the tables below (lines 93, 95, 129, 131), but the diagram itself doesn't distinguish. This is acceptable for a presentation prep document.
- **Fix:** No change required -- the tables provide the phase detail.

### ISSUE F-3 (MINOR): Long table cells in Implementation Guide may wrap poorly in PDF
- **File:** `02_Implementation_Guide.md`, Lines 400--416
- **Issue:** Several table cells in Section 8 (Compliance & Security) are very long (100+ characters). In PDF conversion with narrow columns, these may wrap in ways that are hard to read.
- **Fix:** Test in PDF output. If wrapping is poor, consider breaking the longest cells into bullet points within the cell or splitting the table.

---

## 6. TONE

### ISSUE T-1 (INFO): Tone is appropriate for internal and investor-facing use
- **Files:** Both documents
- **Issue:** The Technical Brief is informal/conversational where appropriate (talk-to sections) and technical elsewhere -- correct for a presentation prep document. The Implementation Guide is direct and operational -- correct for a build plan. Both are appropriate for their intended audience.
- **Fix:** None needed.

---

## 7. COMPLETENESS

### ISSUE CO-1 (MAJOR): No "Hard Questions" prep section in Technical Brief
- **File:** `01_VV_Technical_Brief.md`
- **Issue:** The Q&A prep (Section 7) covers friendly questions but does not prepare for adversarial questions. The review (01_review.md) recommended adding a "Hard Questions" section covering:
  - "What clinical validation have you completed?"
  - "Why wouldn't an existing player just build this?"
  - "What happens if the pilot fails?"
  - "What's your FDA regulatory risk?"
- **Fix:** Add a subsection after Section 7 with prepared responses to adversarial questions.

### ISSUE CO-2 (MAJOR): Implementation Guide lacks testing strategy
- **File:** `02_Implementation_Guide.md`
- **Issue:** No mention of unit testing, integration testing, UAT, or regression testing methodology. For a healthcare platform handling PHI and billing, testing is not optional. Should include: Apex test coverage targets (75% minimum for Salesforce deployment, 85%+ recommended), integration test plan for EHR/RPM connections, and UAT protocol with pilot clinic staff.
- **Fix:** Add a brief testing strategy subsection to Section 4 or Section 8.

### ISSUE CO-3 (MINOR): No patient consent workflow mentioned
- **File:** `02_Implementation_Guide.md`
- **Issue:** RPM enrollment requires patient consent (clinical consent and Medicare consent for RPM billing). The platform needs a consent capture workflow. This is a legal requirement for RPM billing.
- **Fix:** Add a note to the RPM Billing Tracker row (line 179) or a new row mentioning consent capture as a Phase 1 requirement.

---

## 8. CROSS-REFERENCE MATRIX

| Data Point | Technical Brief | Implementation Guide | Consistent? |
|---|---|---|---|
| Virginia RHC count | 106 RHCs + 27 FQHCs | Not stated directly | YES |
| National RHC count | 5,500+ | Not stated directly | N/A |
| Phase 1 timeline | Months 1--4 | Months 1--4 | YES |
| Phase 1 budget | $50K grant + $123K sweat = $173K | $50,000 cash + ~$123,000 in-kind = ~$173,000 | YES |
| Pilot clinic count (Phase 1) | 2--3 | 2--3 | YES |
| SaaS pricing | $2,000--$4,000/month | $500--$4,000/month (3 tiers) | YES (Brief uses mid-tier) |
| Revenue unlock per clinic | $195K--$267K/year | $195,000--$267,000/year | YES |
| RPM per patient/month | $100--$180 (99454+99457+extra) | $103.88 (99454+99457 only) | YES (Brief's range encompasses Guide) |
| Risk model AUC-ROC target | >0.75 | >0.75 | YES |
| Risk model sensitivity target | >80% top decile | >80% top decile | YES |
| ML framework | gradient-boosted ensemble | XGBoost + logistic regression | YES |
| SHAP interpretability | Yes (mentioned in Tai Mai talk-to) | Yes (Section 3.2 ML spec) | YES |
| EHR targets | eCW, athenahealth, MEDITECH, Azalea | eCW, athenahealth, MEDITECH, Azalea, TruBridge | YES (Brief omits TruBridge for brevity) |
| RPM devices | Tenovi, Smart Meter (cellular) | Tenovi, Smart Meter (cellular) | YES |
| Phase 1 integration | Salesforce Connect + Apex REST | Salesforce Connect + Named Credentials + Apex REST | YES |
| Phase 2 integration | MuleSoft | MuleSoft | YES |
| Salesforce users (Phase 1) | 5 | 5 | YES |
| SF license cost | $8,450 | $8,450 | YES |
| Contract SF developer | $30,000 | $30,000 | YES |
| GCP hosting | $2,000 | $2,000 | YES |
| Legal | $2,000 | $2,000 | YES |
| ML compute | $1,500 | $1,500 | YES |
| Miscellaneous | $1,550 | $1,550 | YES |
| Pilot onboarding | $4,500 | $3,000 (travel/training) + $1,500 (devices) = $4,500 | YES |
| MIPS categories | Quality, Cost, PI, IA | Quality 30%, Cost 30%, PI 25%, IA 15% | YES |
| MIPS max penalty | -9% | -9% | YES |
| Encryption | AES-256, TLS 1.2+ | AES-256, TLS 1.2+ | YES |
| Clearinghouse (Phase 2) | Office Ally first | Office Ally first | YES |
| Phase 1 EHR integration count | 1 system | 1 system | YES |
| NLP coding optimization phase | Phase 2 | Phase 2 | YES |
| HRSA UDS phase | Phase 2 | Phase 2 | YES |
| Regulatory Change Engine phase | Phase 3 | Phase 3 | YES |
| Denial Prevention phase | Phase 3 | Phase 3 | YES |

---

## 9. PRIORITY ACTION ITEMS

### Must Fix Before Presentation (Major)
1. Fix CRM Analytics references in Technical Brief to say "Reports & Dashboards" for Phase 1 (C-1)
2. Fix NLP in Phase 1 MVP diagram -- should not show coding NLP (C-2/F-1)
3. Update Phase 2 cost summary to reflect $80K MuleSoft (C-3)
4. Fix MuleSoft cost reference in line 71 text (A-1)
5. Fix "Silverline" as small firm (C-4)
6. Add Hard Questions prep section to Technical Brief (CO-1)
7. Fix "Heath care" typo (G-1)

### Should Fix (Minor)
8. Add testing strategy note to Implementation Guide (CO-2)
9. Add patient consent workflow mention (CO-3)
10. Add note about new 2026 RPM code revenue impact (A-2)
11. eCW physician count clarification (A-4)

---

*End of AI Quality Check Results*
*Generated: February 24, 2026*
